Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Purpose To assess therapeutic and prognostic implications of perfusion characterization by fractal analysis using routine MRI in high-risk primary neuroblastomas and to establish a pathophysiologic connection between vascularity phenotype, perfusion imaging characteristics, and treatment response. Materials and Methods In a retrospective cohort study across 30 centers, MRI data of patients with high-risk neuroblastoma (June 2005-February 2021) were collected at the time point of diagnosis (TP1) and after induction chemotherapy before surgery (TP2), with data split into separate discovery (single-center) and validation cohorts (29 centers). Fractal analysis was performed on contrast-enhanced, fat-saturated, T1-weighted sequences at both time points to obtain voxel-wise local fractal dimension (FD) maps for predicting volumetric tumor response. The association of global FD with event-free survival (EFS) was assessed using a Cox proportional hazards model. Additionally, FD was calculated from CD34-stained endothelium in selected histologic tumor samples. Accuracy of response prediction, prognostic value for EFS, and correlation between FD of immunohistochemical vascularity and MRI-derived perfusion were also evaluated. Results In 73 patients (median age, 3 years [IQR, 3]; 39 male patients; discovery cohort, n = 36; validation cohort, n = 37), local FD maps helped predict volumetric tumor response to induction chemotherapy between TP1 and TP2 with good accuracy (root mean squared error, 47.78 mL; R2 = 0.94; P < .001), visualizing intratumor high perfusion complexity in areas with low response potential. In multivariate Cox proportional hazards modeling, MYCN status (hazard ratio, 2.30; 95% CI: 1.16, 4.55; P = .017) and global FD at TP2 (hazard ratio, 0.65; 95% CI: 0.47, 0.88; P = .006) were significantly associated with EFS. Complexity of both CD34-immunohistochemical microvascularity (1.23 ± 0.09 [SD] to 1.44 ± 0.07, P < .001) and MRI perfusion (3.40 ± 0.04 to 3.53 ± 0.07, P < .001) increased throughout induction chemotherapy. Conclusion Fractal analysis of MRI-derived perfusion complexity was associated with spatial heterogeneity of chemotherapy response and stratified prognosis in MYCN nonamplified high-risk neuroblastoma, supporting its potential as an imaging biomarker linked to microvascular architecture. German Clinical Trial Registry: DRKS00023442 Keywords: Pediatrics, MR-Imaging, Nervous-Peripheral, Fractal Analysis, Tissue Characterization, Tumor Response Supplemental material is available for this article. © RSNA, 2025.